 |
|
|
| |
Preclinical Profiles of IDX136 and IDX316, Two Novel Macrocyclic HCV Protease Inhibitors
|
| |
| |
44th EASL April 25 2009 Copenhagen Denmark- home and birthplace of the real Danishes
Reported by Jules Levin
L.B. Lallos1, J.P. Bilello1, M.A. Soubasakos1, J. Gillum1, M. La Colla1, I. Serra1, M. Liuzzi3, J. McCarville1, M. Seifer1, S.S. Good1, M. Larsson1, J. Selden1, C. Parsy2, D. Surleraux2 and D.N. Standring1
1Idenix Pharmaceuticals, Inc., Cambridge, MA, USA; 2Idenix Pharmaceuticals, Inc., Montpellier, France; 3Idenix Pharmaceuticals, Inc., Cagliari, Italy
|
| |
|
|
|
|
|
